Oestrogen therapy for multiple sclerosis: Not the way forward [1]

International MS Journal

Volumn 10, Issue 3, 2003, Pages 98-

  Hutchinson, Michael ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRIOL;

BREAST CANCER; BREAST FEEDING; CANCER RISK; CLINICAL TRIAL; DELIVERY; DISABILITY; DISEASE ACTIVITY; DRUG EFFICACY; ESTROGEN THERAPY; FEMALE; HUMAN; LETTER; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREGNANCY; PUERPERIUM; RELAPSE; THROMBOEMBOLISM; UTERUS CANCER;

ESTROGENS; FEMALE; HUMANS; MULTIPLE SCLEROSIS; PREGNANCY; PREGNANCY COMPLICATIONS; SEVERITY OF ILLNESS INDEX;

EID: 0141534377     PISSN: 13528963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. N Engl J Med 1998; 339: 285-291.
2. Sicotte NL, Liva SM, Klutch R, Pfeiffer P, Bouvier S, Odesa S et al. Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol 2002; 52: 421-428.
3. Miller DH, Molyneux PD, Barker GJ, MacManus DG, Moseley IF, Wagner K. Effect of interferon-beta 1 b on magnetic resonanance imaging outcomes in secondary progressive multiple sclerosis: results of a European multicenter, randomized, double-blind, placebo-controlled trial. Ann Neurol 1999; 46: 850-859.
4. Li DK, Zhao GJ, Paty DW. Randomized controlled trial of interferon-beta-1a in secondary progressive MS: MRI results. Neurology 2001; 56: 1505-1513.
5. Miller DH, Khan OA, Sheremata WA, Blumhardt LD, Rice GP, Libonati MA et al. A controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 2003; 348: 15-23.